St. Mary’s Medical Center & the Palm Beach Children’s Hospital Becomes First Hospital in the Region to Use Flow Diverter for Treatment of Unruptured Intracranial Aneurysms

West Palm Beach, Fla. - 3/29/2019 - St. Mary’s Medical Center is the first hospital in Palm Beach and Broward counties to use the Surpass Streamline Flow Diverter to treat unruptured large and giant wide neck intracranial aneurysms. The device is the second flow diverting stent to gain FDA approval in the U.S. It is also approved and available in many markets around the world.

“We’re honored to be the only hospital in the region with the capacity to treat patients requiring this innovative treatment,” said hospital CEO Gabrielle Finley-Hazle. “For more than 10 years, the team at our Comprehensive Stroke Center, has made it their mission to continue bringing the most advanced services to our community.”

The tight wire mesh of the device restricts blood from entering the sac of the intracranial aneurysm, which helps to promote clotting. The Surpass Streamline Flow Diverter is indicated for the treatment of brain aneurysms in patients 18 years of age and older. The device is intended to treat large or giant saccular intracranial aneurysms with a wide-neck (neck width 4 mm or wider or dome-to-neck ratio less than 2) or fusiform intracranial aneurysms (an elongated, spindle shaped aneurysm involving the entire vessel wall) in the internal carotid artery (which supplies blood to the brain) with a diameter between 2.5 mm and 5.3 mm.

"Some uruptured aneurysms can be more challenging due to their location and surrounding anatomy. Having this technology is an important advantage for physicians and patients," said Dr. Ali Malek, medical director of the Comprehensive Stroke Center at St. Mary’s Medical Center & the Palm Beach Children’s Hospital. "The stent is designed to reliably open and provide consistent mesh density across the neck of the aneurysm to aid in aneurysm occlusion.”